| |
| |
|
| Insider
Information: |
Zaccardelli David |
| Relationship: |
President & CEO, Direc... |
| City: |
Silver Spring |
| State: |
MD |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
48,042 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$409,736 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
48,042 |
|
|
| Total
Value |
$409,736 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
United Therapeutics Corp |
UTHR |
EVP & Chief Operating ... |
2016-05-13 |
1,542 |
|
0 |
Premium* |
|
|
Melinta Therapeutics, Inc |
MLNT |
Director |
2018-05-29 |
46,500 |
2018-05-29 |
0 |
Premium* |
|
|
Dova Pharmaceuticals, Inc. |
DOVA |
President & CEO, Direc... |
2019-11-12 |
0 |
2018-12-19 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| DOVA |
Dova Pharmaceuticals, Inc... |
President & CEO |
• • – |
2019-11-12 |
4 |
D |
$0.00 |
$0 |
D/D |
(76,647) |
0 |
0 |
- |
|
| DOVA |
Dova Pharmaceuticals, Inc... |
President & CEO |
• • – |
2019-10-01 |
4 |
AS |
$27.90 |
$147,173 |
D/D |
(5,275) |
76,647 |
0 |
- |
|
| DOVA |
Dova Pharmaceuticals, Inc... |
President & CEO |
• • – |
2019-07-02 |
4 |
AS |
$15.73 |
$166,608 |
D/D |
(10,450) |
81,922 |
0 |
- |
|
| DOVA |
Dova Pharmaceuticals, Inc... |
President & CEO |
• – – |
2018-12-20 |
4 |
B |
$6.07 |
$60,700 |
D/D |
10,000 |
92,372 |
2.74 |
- |
|
| DOVA |
Dova Pharmaceuticals, Inc... |
President & CEO |
• – – |
2018-12-19 |
4 |
A |
$0.00 |
$0 |
D/D |
82,372 |
82,372 |
0 |
- |
|
| MLNT |
Melinta Therapeutics, Inc |
Director |
– • – |
2018-05-29 |
4 |
B |
$5.00 |
$200,000 |
D/D |
40,000 |
46,500 |
2.39 |
- |
|
| UTHR |
United Therapeutics Corp |
EVP & Chief Operating Officer |
• • – |
2016-05-13 |
4 |
D |
$111.48 |
$12,402,150 |
D/D |
(111,250) |
1,542 |
0 |
- |
|
| UTHR |
United Therapeutics Corp |
EVP & Chief Operating Officer |
• • – |
2016-05-13 |
4 |
OE |
$47.50 |
$7,798,015 |
D/D |
111,250 |
112,792 |
0 |
- |
|
| UTHR |
United Therapeutics Corp |
EVP & Chief Operating Officer |
• • – |
2015-12-29 |
4 |
D |
$159.23 |
$318,460 |
D/D |
(2,000) |
1,375 |
0 |
- |
|
| UTHR |
United Therapeutics Corp |
EVP & Chief Operating Officer |
• • – |
2015-12-29 |
4 |
OE |
$65.80 |
$131,600 |
D/D |
2,000 |
3,375 |
0 |
- |
|
| UTHR |
United Therapeutics Corp |
EVP & Chief Operating Officer |
• • – |
2015-12-22 |
4 |
OE |
$65.80 |
$131,600 |
D/D |
2,000 |
3,375 |
0 |
- |
|
| UTHR |
United Therapeutics Corp |
EVP & Chief Operating Officer |
• • – |
2015-12-22 |
4 |
D |
$157.93 |
$315,860 |
D/D |
(2,000) |
1,375 |
0 |
- |
|
| UTHR |
United Therapeutics Corp |
EVP & Chief Operating Officer |
• • – |
2015-12-15 |
4 |
D |
$159.97 |
$319,940 |
D/D |
(2,000) |
1,375 |
0 |
- |
|
| UTHR |
United Therapeutics Corp |
EVP & Chief Operating Officer |
• • – |
2015-12-15 |
4 |
OE |
$65.80 |
$131,600 |
D/D |
2,000 |
3,375 |
0 |
- |
|
| UTHR |
United Therapeutics Corp |
EVP & Chief Operating Officer |
• • – |
2015-12-08 |
4 |
D |
$160.30 |
$320,600 |
D/D |
(2,000) |
1,375 |
0 |
- |
|
| UTHR |
United Therapeutics Corp |
EVP & Chief Operating Officer |
• • – |
2015-12-08 |
4 |
OE |
$65.80 |
$131,600 |
D/D |
2,000 |
3,375 |
0 |
- |
|
| UTHR |
United Therapeutics Corp |
EVP & Chief Operating Officer |
• • – |
2015-12-01 |
4 |
D |
$159.00 |
$318,000 |
D/D |
(2,000) |
1,375 |
0 |
- |
|
| UTHR |
United Therapeutics Corp |
EVP & Chief Operating Officer |
• • – |
2015-12-01 |
4 |
OE |
$65.80 |
$131,600 |
D/D |
2,000 |
3,375 |
0 |
- |
|
| UTHR |
United Therapeutics Corp |
EVP & Chief Operating Officer |
• • – |
2015-11-24 |
4 |
OE |
$61.06 |
$126,860 |
D/D |
2,000 |
2,375 |
0 |
- |
|
| UTHR |
United Therapeutics Corp |
EVP & Chief Operating Officer |
• • – |
2015-11-24 |
4 |
D |
$154.23 |
$308,460 |
D/D |
(2,000) |
1,375 |
0 |
- |
|
| UTHR |
United Therapeutics Corp |
EVP & Chief Operating Officer |
• • – |
2015-11-17 |
4 |
D |
$148.02 |
$148,020 |
D/D |
(1,000) |
1,375 |
0 |
- |
|
| UTHR |
United Therapeutics Corp |
EVP & Chief Operating Officer |
• • – |
2015-11-17 |
4 |
OE |
$61.06 |
$61,060 |
D/D |
1,000 |
2,375 |
0 |
- |
|
| UTHR |
United Therapeutics Corp |
EVP & Chief Operating Officer |
• • – |
2015-11-10 |
4 |
D |
$156.75 |
$313,500 |
D/D |
(2,000) |
1,375 |
0 |
- |
|
| UTHR |
United Therapeutics Corp |
EVP & Chief Operating Officer |
• • – |
2015-11-10 |
4 |
OE |
$61.06 |
$122,120 |
D/D |
2,000 |
3,375 |
0 |
- |
|
| UTHR |
United Therapeutics Corp |
EVP & Chief Operating Officer |
• • – |
2015-11-03 |
4 |
D |
$152.60 |
$305,200 |
D/D |
(2,000) |
1,375 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
